%0 Journal Article
%K All-cause mortality
%K Cardiovascular outcomes
%K Effect modifier
%K Hospitalization for heart failure
%K Major adverse cardiovascular events
%K obesity
%K Sodium-glucose cotransporter-2 inhibitors
%B Diabetes Res Clin Pract
%D 2022
%G eng
%M 36167266
%P 110094
%R 10.1016/j.diabres.2022.110094
%T Obesity as a modifier of the cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes
%V 192
%7 2022/09/28
%@ 0168-8227